首页 > 最新文献

Casopis lekaru ceskych最新文献

英文 中文
Practical recommendations for the management of children after kidney and liver transplantation. 儿童肾和肝移植后处理的实用建议。
Q4 Medicine Pub Date : 2023-01-01
Jakub Zieg, David Bauer, Vlasta Krejčová, Lucie Gonsorčíková

The number of pediatric solid organ transplantations is growing. This therapy leads often to better quality of life but also brings some specific complications. Our review summarizes practical recommendations for long-time care of the children after kidney and liver transplantation. The knowledge of the issues related to transplantation is essential for the first contact physicians, whose cooperation with transplant centre contributes highly to adequate management of these children.

儿童实体器官移植的数量正在增长。这种疗法通常会提高生活质量,但也会带来一些特定的并发症。我们的综述总结了肾脏和肝脏移植后儿童长期护理的实用建议。与移植有关的问题的知识对第一次接触的医生是必不可少的,他们与移植中心的合作对这些儿童的适当管理有很大的帮助。
{"title":"Practical recommendations for the management of children after kidney and liver transplantation.","authors":"Jakub Zieg,&nbsp;David Bauer,&nbsp;Vlasta Krejčová,&nbsp;Lucie Gonsorčíková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The number of pediatric solid organ transplantations is growing. This therapy leads often to better quality of life but also brings some specific complications. Our review summarizes practical recommendations for long-time care of the children after kidney and liver transplantation. The knowledge of the issues related to transplantation is essential for the first contact physicians, whose cooperation with transplant centre contributes highly to adequate management of these children.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 7-8","pages":"296-302"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9393219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical principles for the usage and sharing of genomic data from researc. 研究中基因组数据使用和共享的伦理原则。
Q4 Medicine Pub Date : 2023-01-01
Věra Franková, Hana Svozilová, Viktor Stránecký, Kateřina Staňo Kozubík, Josef Srovnal, Lucie Benešová, Magdalena Uvírová, Milan Macek, Šárka Pospíšilová

The current significant development of human genome/exome sequencing in biomedical research is one of the important paths leading to personalized medicine. However, sequencing of human genetic information generates potentially sensitive and exploitable data, which leads to ethical, legal, and security issues. For this reason, it is necessary to follow several measures when working with these data, applying to their entire life cycle - i.e., acquisition, storage, processing, usage, sharing, archiving, and reuse. In addition, importance of good practice during the whole data life cycle is emphasized by current European trends towards open science and digital transformation. Therefore, the following recommendations have been developed, establishing principles for work with the whole human genome sequences or parts of it in research context. The recommendations are based on two documents published by the Global Alliance for Genomics and Health (GA4GH) and on foreign literature, thus summarizing recent relevant guidance on most aspects of working with human genomic data.

当前人类基因组/外显子组测序在生物医学研究中的重大进展是实现个性化医疗的重要途径之一。然而,人类基因信息的测序会产生潜在的敏感和可利用的数据,从而导致伦理、法律和安全问题。出于这个原因,在处理这些数据时有必要遵循几个措施,并将其应用于它们的整个生命周期——即获取、存储、处理、使用、共享、归档和重用。此外,当前欧洲面向开放科学和数字化转型的趋势强调了在整个数据生命周期中良好实践的重要性。因此,提出了以下建议,建立了在研究背景下使用整个人类基因组序列或部分基因组序列的原则。这些建议基于全球基因组学与健康联盟(GA4GH)发表的两份文件以及国外文献,从而总结了最近关于处理人类基因组数据的大多数方面的相关指导。
{"title":"Ethical principles for the usage and sharing of genomic data from researc.","authors":"Věra Franková,&nbsp;Hana Svozilová,&nbsp;Viktor Stránecký,&nbsp;Kateřina Staňo Kozubík,&nbsp;Josef Srovnal,&nbsp;Lucie Benešová,&nbsp;Magdalena Uvírová,&nbsp;Milan Macek,&nbsp;Šárka Pospíšilová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The current significant development of human genome/exome sequencing in biomedical research is one of the important paths leading to personalized medicine. However, sequencing of human genetic information generates potentially sensitive and exploitable data, which leads to ethical, legal, and security issues. For this reason, it is necessary to follow several measures when working with these data, applying to their entire life cycle - i.e., acquisition, storage, processing, usage, sharing, archiving, and reuse. In addition, importance of good practice during the whole data life cycle is emphasized by current European trends towards open science and digital transformation. Therefore, the following recommendations have been developed, establishing principles for work with the whole human genome sequences or parts of it in research context. The recommendations are based on two documents published by the Global Alliance for Genomics and Health (GA4GH) and on foreign literature, thus summarizing recent relevant guidance on most aspects of working with human genomic data.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 7-8","pages":"271-275"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9393220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypercapnic respiratory failure - review. 高碳酸血症性呼吸衰竭-回顾。
Q4 Medicine Pub Date : 2023-01-01
Martin Vykopal, Jan Mizera, Petr Jakubec, Samuel Genzor, Pavol Pobeha

This review summarizes the issue of acute hypercapnic respiratory failure. Acute respiratory failure is a condition in which the respiratory system is unable to fulfill its basic function, i.e. enriching the blood with oxygen and excreting carbon dioxide. Chronologically, we divide it into acute and chronic, and according to the manifestation into hypoxemic or hypoxemic with hypercapnia. Multiple factors, such as reduced ventilation and increased dead space, contribute to the development of hypoxemic-hypercapnic (global) respiratory failure. Both the patient's clinical presentation and laboratory examination of blood gases and acid-base balance (preferably from arterial blood) are used for diagnosis. In the absence of contraindications, non-invasive ventilation is used to establish normocapnia.

本文综述了急性高碳酸血症性呼吸衰竭的相关问题。急性呼吸衰竭是指呼吸系统不能完成其基本功能,即不能向血液中输送氧气和排出二氧化碳。按时间顺序分为急性和慢性,按表现分为低氧血症或低氧血症伴高碳酸血症。通气减少和死亡空间增加等多种因素可导致低氧血症-高碳酸血症(全局性)呼吸衰竭。患者的临床表现和血气和酸碱平衡的实验室检查(最好来自动脉血)用于诊断。在无禁忌症的情况下,使用无创通气来建立正常呼吸功能。
{"title":"Hypercapnic respiratory failure - review.","authors":"Martin Vykopal,&nbsp;Jan Mizera,&nbsp;Petr Jakubec,&nbsp;Samuel Genzor,&nbsp;Pavol Pobeha","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This review summarizes the issue of acute hypercapnic respiratory failure. Acute respiratory failure is a condition in which the respiratory system is unable to fulfill its basic function, i.e. enriching the blood with oxygen and excreting carbon dioxide. Chronologically, we divide it into acute and chronic, and according to the manifestation into hypoxemic or hypoxemic with hypercapnia. Multiple factors, such as reduced ventilation and increased dead space, contribute to the development of hypoxemic-hypercapnic (global) respiratory failure. Both the patient's clinical presentation and laboratory examination of blood gases and acid-base balance (preferably from arterial blood) are used for diagnosis. In the absence of contraindications, non-invasive ventilation is used to establish normocapnia.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 1","pages":"13-18"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9845547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic drug monitoring in psychiatry. 精神病学中的治疗药物监测。
Q4 Medicine Pub Date : 2023-01-01
Eva Češková, Petr Šilhán

In medicine, there are two main methods of improving the healthcare provided: perfecting (optimizing) the existing ones and seeking new treatment procedures. Despite of tremendous development in the central nervous system research, current treatment of severe mental illnesses, such as schizophrenia and depressive disorder, is suboptimal. Nowadays, optimization of treatment in psychiatry includes therapeutic drug monitoring (TDM) and pharmacogenomic testing, which examines genetic variation involved in medication metabolism and drug action. The TDM enables to determine drug concentrations in blood and adjust the dose accordingly if clinical effects correlate better with drug blood levels than drug doses. The first international guidelines for TDM in neuropsychopharmacology were published in 2004 and regularly updated. The recent update provides therapeutic reference ranges for a majority of commonly prescribed psychiatric medications and gives example of patients regularly treated in clinical practice profiting from TDM (using antipsychotics and changing their smoking habits). TDM in psychiatry is an underused tool, given its ability to optimize treatment, as well as to improve treatment effectiveness.

在医学上,有两种主要的方法来改善所提供的医疗保健:完善(优化)现有的方法和寻求新的治疗程序。尽管中枢神经系统研究取得了巨大进展,但目前对精神分裂症和抑郁障碍等严重精神疾病的治疗并不理想。如今,精神病学治疗的优化包括治疗药物监测(TDM)和药物基因组测试,后者检查药物代谢和药物作用中的基因变异。TDM能够确定血液中的药物浓度,并在临床效果与药物血液水平的相关性比药物剂量更好的情况下相应地调整剂量。2004年发布了第一份神经药理学TDM国际指南,并定期更新。最近的更新提供了大多数常用精神病药物的治疗参考范围,并举例说明了在临床实践中定期接受治疗的患者从TDM中获益(使用抗精神病药物并改变吸烟习惯)。TDM在精神病学中是一种未被充分利用的工具,因为它能够优化治疗并提高治疗效果。
{"title":"Therapeutic drug monitoring in psychiatry.","authors":"Eva Češková,&nbsp;Petr Šilhán","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In medicine, there are two main methods of improving the healthcare provided: perfecting (optimizing) the existing ones and seeking new treatment procedures. Despite of tremendous development in the central nervous system research, current treatment of severe mental illnesses, such as schizophrenia and depressive disorder, is suboptimal. Nowadays, optimization of treatment in psychiatry includes therapeutic drug monitoring (TDM) and pharmacogenomic testing, which examines genetic variation involved in medication metabolism and drug action. The TDM enables to determine drug concentrations in blood and adjust the dose accordingly if clinical effects correlate better with drug blood levels than drug doses. The first international guidelines for TDM in neuropsychopharmacology were published in 2004 and regularly updated. The recent update provides therapeutic reference ranges for a majority of commonly prescribed psychiatric medications and gives example of patients regularly treated in clinical practice profiting from TDM (using antipsychotics and changing their smoking habits). TDM in psychiatry is an underused tool, given its ability to optimize treatment, as well as to improve treatment effectiveness.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 4","pages":"148-151"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41099289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change in the prevalence of overweight/obesity in Czech seven-year-old children between 2008 and 2019. 2008年至2019年间捷克7岁儿童超重/肥胖患病率的变化。
Q4 Medicine Pub Date : 2023-01-01
Tereza Metelcová, Hana Zamrazilová, Bohuslav Procházka, Radka Taxová Braunerová, Marie Kunešová

World Health Organization (WHO) Europe organizes Childhood Obesity Surveillance Initiative (COSI), in which the Czech Republic participates since the beginning. The aim of this project is to monitor the prevalence of overweight and obesity of 7-year-old children in the Czech Republic. Data were obtained from 2349 children examined by 72 pediatricians across the Czech Republic. Anthropometric parameters were measured and subjects filled questionnaire. The prevalence of obesity and overweight did not change significantly between 2008 and 2019. Although in the fifth round in 2019, the prevalence of obesity increased and the prevalence of overweight slightly decreased in both sexes. In 2019 6.09 % of boys and 7.12 % of girl had overweight. The prevalence of obesity in the fifth round was 9.26 % in boys and 8.64 % in girls (assessed according to the Czech reference values). Already in the first round we noticed a relatively high prevalence of severe obesity (3.21 % for boys and 0.8 % for girls), which did not differ significantly between rounds. Even if the prevalence of overweight has not significantly increased until 2019, preventive and treatment programs are very important, because it is an important part of the prevention and early detection of obesity in children.

世界卫生组织(世界卫生组织)欧洲组织了儿童肥胖监测倡议(COSI),捷克共和国从一开始就参与了该倡议。该项目的目的是监测捷克共和国7岁儿童超重和肥胖的流行情况。数据来自捷克共和国72名儿科医生对2349名儿童进行的检查。测量人体测量参数,受试者填写问卷。2008年至2019年间,肥胖和超重的患病率没有显著变化。尽管在2019年的第五轮中,男女肥胖患病率都有所上升,超重患病率略有下降。2019年,6.09%的男孩和7.12%的女孩超重。第五轮调查中,男孩和女孩的肥胖率分别为9.26%和8.64%(根据捷克参考值评估)。在第一轮中,我们已经注意到严重肥胖的患病率相对较高(男孩为3.21%,女孩为0.8%),各轮之间没有显著差异。即使超重的患病率直到2019年才显著增加,预防和治疗计划也非常重要,因为这是预防和早期发现儿童肥胖的重要组成部分。
{"title":"Change in the prevalence of overweight/obesity in Czech seven-year-old children between 2008 and 2019.","authors":"Tereza Metelcová,&nbsp;Hana Zamrazilová,&nbsp;Bohuslav Procházka,&nbsp;Radka Taxová Braunerová,&nbsp;Marie Kunešová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>World Health Organization (WHO) Europe organizes Childhood Obesity Surveillance Initiative (COSI), in which the Czech Republic participates since the beginning. The aim of this project is to monitor the prevalence of overweight and obesity of 7-year-old children in the Czech Republic. Data were obtained from 2349 children examined by 72 pediatricians across the Czech Republic. Anthropometric parameters were measured and subjects filled questionnaire. The prevalence of obesity and overweight did not change significantly between 2008 and 2019. Although in the fifth round in 2019, the prevalence of obesity increased and the prevalence of overweight slightly decreased in both sexes. In 2019 6.09 % of boys and 7.12 % of girl had overweight. The prevalence of obesity in the fifth round was 9.26 % in boys and 8.64 % in girls (assessed according to the Czech reference values). Already in the first round we noticed a relatively high prevalence of severe obesity (3.21 % for boys and 0.8 % for girls), which did not differ significantly between rounds. Even if the prevalence of overweight has not significantly increased until 2019, preventive and treatment programs are very important, because it is an important part of the prevention and early detection of obesity in children.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 5","pages":"203-206"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71478480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of nutritional intervention combined with vitamin D on the development of sarcopenia. 结合维生素 D 的营养干预对肌肉疏松症发展的影响。
Q4 Medicine Pub Date : 2023-01-01
Tereza Koribaničová, Hana Matějovská Kubešová

The aim of the review article was to analyze studies dealing with the implementation of nutritional intervention with vitamin D content and nutritional intervention including vitamin D in combination with resistance exercise. All these interventions are being investigated in patients with and without sarcopenia. PubMed, CINAHL and MEDLINE databases were used to search for studies. Studies from 2017-2022, in Czech and English, were searched for. All studies had to be freely accessible in fulltext and had to focus on patients older than 65 years. Only meta-analyses and randomized controlled trials (RCTs) were included in the review. A total of 5 RCTs were included in the review. These can be thematically divided into studies devoted to nutritional intervention (1) and studies devoted to nutritional intervention in combination with resistance exercise (4), where the results were most reliable. It can be concluded that the administration of nutritional intervention enriched with vitamin D, with is combined with resistance exercise, can improve vitamin D values, muscle strength and physical fitness in seniors over 65 years of age.

这篇综述文章的目的是分析有关实施含有维生素 D 的营养干预以及将维生素 D 与阻力运动相结合的营养干预的研究。所有这些干预措施都是针对肌肉疏松症患者和非肌肉疏松症患者进行研究的。研究使用 PubMed、CINAHL 和 MEDLINE 数据库进行搜索。搜索了 2017-2022 年间的捷克语和英语研究。所有研究的全文均可免费查阅,且研究对象必须是 65 岁以上的患者。综述仅包括荟萃分析和随机对照试验(RCT)。综述共纳入了 5 项随机对照试验。这些研究可按主题分为营养干预研究(1 项)和营养干预与阻力运动相结合的研究(4 项),其中营养干预与阻力运动相结合的研究结果最为可靠。可以得出的结论是,富含维生素 D 的营养干预与阻力运动相结合,可以改善 65 岁以上老年人的维生素 D 值、肌肉力量和体能。
{"title":"Influence of nutritional intervention combined with vitamin D on the development of sarcopenia.","authors":"Tereza Koribaničová, Hana Matějovská Kubešová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The aim of the review article was to analyze studies dealing with the implementation of nutritional intervention with vitamin D content and nutritional intervention including vitamin D in combination with resistance exercise. All these interventions are being investigated in patients with and without sarcopenia. PubMed, CINAHL and MEDLINE databases were used to search for studies. Studies from 2017-2022, in Czech and English, were searched for. All studies had to be freely accessible in fulltext and had to focus on patients older than 65 years. Only meta-analyses and randomized controlled trials (RCTs) were included in the review. A total of 5 RCTs were included in the review. These can be thematically divided into studies devoted to nutritional intervention (1) and studies devoted to nutritional intervention in combination with resistance exercise (4), where the results were most reliable. It can be concluded that the administration of nutritional intervention enriched with vitamin D, with is combined with resistance exercise, can improve vitamin D values, muscle strength and physical fitness in seniors over 65 years of age.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"162 6","pages":"251-255"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The importance of lung biopsy in a patient with idiopathic pulmonary fibrosis: a case report. 特发性肺纤维化患者肺活检的重要性:1例报告。
Q4 Medicine Pub Date : 2022-01-01
Josef Kaláb, Ester Lišková, Jaroslava Dušková

Idiopathic pulmonary fibrosis (IPF) is a severe progressive fibrotic disease of the lung. Its etiology is not yet completely clear. The affected population is exclusively older than 40 years with maximum incidence in the age categories of 60 to 70 years. Its worldwide prevalence varies from 2 to 29/100 000 people (in the Czech Republic 5-6/100 000). Annual incidence is constantly rising, mainly thanks to the ever-improving diagnostic possibilities. Untreated IPF disease causes rapid structural and functional devastation of the lungs with development of respiratory insufficiency and death of the patient within 2 to 3 years after diagnosis, prognosis with IPF is therefore fully (without any exaggeration) comparable to untreated bronchogenic carcinoma. In recent years, the prognosis and quality of life of patients have significantly improved thanks to available specific antifibrotic treatment, which can substantially slow down the disease progression and thus prolong survival. However, a necessary condition for the timely treatment initiation is a quick and accurate diagnosis. The following case report describes a protracted journey to the correct diagnosis in a patient with atypical radiological findings, so that the definitive diagnosis was established only as a result of a surgical lung biopsy.

特发性肺纤维化(IPF)是一种严重的进行性肺纤维化疾病。其病因尚不完全清楚。受影响的人口完全是40岁以上,发病率最高的年龄组是60至70岁。其在世界范围内的流行率为2至29/10万人(在捷克共和国为5至6/10万人)。年发病率不断上升,主要是由于不断提高诊断的可能性。未经治疗的IPF疾病会导致肺部快速的结构和功能破坏,并发展为呼吸功能不全,患者在诊断后2至3年内死亡,因此IPF的预后完全(毫不夸张)与未经治疗的支气管源性癌相当。近年来,由于可获得特异性抗纤维化治疗,患者的预后和生活质量显著改善,可显著减缓疾病进展,从而延长生存期。然而,及时开始治疗的必要条件是快速准确的诊断。下面的病例报告描述了一个长时间的旅程,以正确的诊断,在病人的非典型影像学表现,因此,明确的诊断是建立只有作为手术肺活检的结果。
{"title":"The importance of lung biopsy in a patient with idiopathic pulmonary fibrosis: a case report.","authors":"Josef Kaláb,&nbsp;Ester Lišková,&nbsp;Jaroslava Dušková","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis (IPF) is a severe progressive fibrotic disease of the lung. Its etiology is not yet completely clear. The affected population is exclusively older than 40 years with maximum incidence in the age categories of 60 to 70 years. Its worldwide prevalence varies from 2 to 29/100 000 people (in the Czech Republic 5-6/100 000). Annual incidence is constantly rising, mainly thanks to the ever-improving diagnostic possibilities. Untreated IPF disease causes rapid structural and functional devastation of the lungs with development of respiratory insufficiency and death of the patient within 2 to 3 years after diagnosis, prognosis with IPF is therefore fully (without any exaggeration) comparable to untreated bronchogenic carcinoma. In recent years, the prognosis and quality of life of patients have significantly improved thanks to available specific antifibrotic treatment, which can substantially slow down the disease progression and thus prolong survival. However, a necessary condition for the timely treatment initiation is a quick and accurate diagnosis. The following case report describes a protracted journey to the correct diagnosis in a patient with atypical radiological findings, so that the definitive diagnosis was established only as a result of a surgical lung biopsy.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 6","pages":"242-246"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10419320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anaesthesia for non-cardiac surgical procedures in patients after heart transplantation. 心脏移植后非心脏手术的麻醉。
Q4 Medicine Pub Date : 2022-01-01
Jan Šoltés, Hynek Říha, Jan Bruthans, Petr Kramář, Milan Ročeň

Over the last 5 years, around 75 heart transplantations a year have been performed in the Czech Republic. According to these data and longer survival of these patients, it is obvious that non-cardiac surgical procedures in this particular group of patients are not rare. In the patients after heart transplantation, there is a significantly higher risk of undergoing elective and emergency surgical procedures due to various reasons. Appropriate anaesthesia and perioperative care are fundamentally affected by the knowledge of pathophysiological and pharmacological differences of transplanted heart. An equally important aspect is a lifetime immunosuppressive therapy in these patients.

在过去的5年里,捷克共和国每年进行大约75例心脏移植手术。根据这些数据和这些患者较长的生存期,很明显,非心脏手术在这一特殊患者群体中并不罕见。在心脏移植后的患者中,由于各种原因,接受选择性和紧急外科手术的风险明显较高。正确的麻醉和围手术期护理从根本上取决于对移植心脏病理生理和药理差异的认识。一个同样重要的方面是对这些患者终生免疫抑制治疗。
{"title":"Anaesthesia for non-cardiac surgical procedures in patients after heart transplantation.","authors":"Jan Šoltés,&nbsp;Hynek Říha,&nbsp;Jan Bruthans,&nbsp;Petr Kramář,&nbsp;Milan Ročeň","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Over the last 5 years, around 75 heart transplantations a year have been performed in the Czech Republic. According to these data and longer survival of these patients, it is obvious that non-cardiac surgical procedures in this particular group of patients are not rare. In the patients after heart transplantation, there is a significantly higher risk of undergoing elective and emergency surgical procedures due to various reasons. Appropriate anaesthesia and perioperative care are fundamentally affected by the knowledge of pathophysiological and pharmacological differences of transplanted heart. An equally important aspect is a lifetime immunosuppressive therapy in these patients.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 3-4","pages":"139-143"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33473536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver tests. 肝脏测试。
Q4 Medicine Pub Date : 2022-01-01
Václav Šmíd

Liver function tests are among the most determined biochemical parameters, and it is essential that their interpretation is always performed correctly. The presence of liver disease is indicated not only by the well-known basic panel of liver function tests (bilirubin, ALT, AST, GGT and ALP), but also by other biochemical parameters, especially albumin, INR and platelet count. The latter analytes are often overlooked, as is the fact that normal values in the baseline liver test panel do not yet rule out advanced chronic liver disease - liver fibrosis or cirrhosis. In contrast, high levels of liver function tests do not automatically indicate liver failure. Considering the increasing incidence of liver disease as well as the rising mortality from liver causes in many European countries, it is desirable to update the diagnostic algorithm when pathological liver function tests are detected.

肝功能测试是最确定的生化参数之一,其解释必须始终正确执行。肝病的存在不仅可以通过众所周知的肝功能基本检查(胆红素、ALT、AST、GGT和ALP)来指示,还可以通过其他生化参数,特别是白蛋白、INR和血小板计数来指示。后一种分析常常被忽视,因为基线肝检查组的正常值还不能排除晚期慢性肝病——肝纤维化或肝硬化。相反,高水平的肝功能检查并不自动表明肝功能衰竭。考虑到肝病发病率的增加以及许多欧洲国家肝病死亡率的上升,当检测到病理性肝功能检查时,需要更新诊断算法。
{"title":"Liver tests.","authors":"Václav Šmíd","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Liver function tests are among the most determined biochemical parameters, and it is essential that their interpretation is always performed correctly. The presence of liver disease is indicated not only by the well-known basic panel of liver function tests (bilirubin, ALT, AST, GGT and ALP), but also by other biochemical parameters, especially albumin, INR and platelet count. The latter analytes are often overlooked, as is the fact that normal values in the baseline liver test panel do not yet rule out advanced chronic liver disease - liver fibrosis or cirrhosis. In contrast, high levels of liver function tests do not automatically indicate liver failure. Considering the increasing incidence of liver disease as well as the rising mortality from liver causes in many European countries, it is desirable to update the diagnostic algorithm when pathological liver function tests are detected.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 2","pages":"52-56"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40150260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Horizon Europe, research and innovation programme until 2027 - what is new comparing with Horizon 2020? 地平线欧洲,到2027年的研究和创新计划——与地平线2020相比,有什么新的?
Q4 Medicine Pub Date : 2022-01-01
Judita Kinkorová

Horizon Europe is the 9th framework programme of European Union (EU) funding research and innovation with the biggest budget ever of €95.5 billion. The main aims of the programme are to boost competitiveness and growth of European Union, to achieve EU sustainable development and to tackle climate change. The programme facilitates collaboration between member states and strengthens the impact of research and innovations. The structure of HEU is similar as in Horizon 2020 based on three pillars: Excellent Science, Global Challenges and European Industrial Competitiveness, and Innovative Europe. Horizon Europe brings several novelties as missions, European partnerships, open science, and gender issues. There are five mission areas and the first one of them is Cancer Mission. European partnership is a new form of objective-driven collaborations bringing together private and/or public partners together to address some of Europe´s most important challenges through concerted research and innovation initiatives. Open science policy is mandatory and refers to the open access to publications and open science principles. In the frame of gender equality strategy, the EU has established a well-established regulatory framework on gender equality, including binding directives, which apply widely across the labour market including the research sector.

地平线欧洲是欧盟(EU)资助研究和创新的第九个框架计划,拥有有史以来最大的预算,达8364.955亿欧元。该计划的主要目标是提高欧盟的竞争力和增长,实现欧盟的可持续发展和应对气候变化。该计划促进了成员国之间的合作,并加强了研究和创新的影响。HEU的结构与“地平线2020”类似,以“卓越科学”、“全球挑战和欧洲产业竞争力”、“创新欧洲”为三大支柱。地平线欧洲带来了几个新奇的任务,欧洲伙伴关系,开放科学和性别问题。有五个任务区域,其中第一个是癌症任务。欧洲伙伴关系是一种目标驱动型合作的新形式,将私人和/或公共合作伙伴聚集在一起,通过协调一致的研究和创新举措来解决欧洲一些最重要的挑战。开放科学政策是强制性的,是指对出版物的开放获取和开放科学原则。在性别平等战略框架内,欧盟建立了完善的性别平等监管框架,包括具有约束力的指令,广泛适用于包括研究部门在内的整个劳动力市场。
{"title":"Horizon Europe, research and innovation programme until 2027 - what is new comparing with Horizon 2020?","authors":"Judita Kinkorová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Horizon Europe is the 9th framework programme of European Union (EU) funding research and innovation with the biggest budget ever of &#8364;95.5 billion. The main aims of the programme are to boost competitiveness and growth of European Union, to achieve EU sustainable development and to tackle climate change. The programme facilitates collaboration between member states and strengthens the impact of research and innovations. The structure of HEU is similar as in Horizon 2020 based on three pillars: Excellent Science, Global Challenges and European Industrial Competitiveness, and Innovative Europe. Horizon Europe brings several novelties as missions, European partnerships, open science, and gender issues. There are five mission areas and the first one of them is Cancer Mission. European partnership is a new form of objective-driven collaborations bringing together private and/or public partners together to address some of Europe´s most important challenges through concerted research and innovation initiatives. Open science policy is mandatory and refers to the open access to publications and open science principles. In the frame of gender equality strategy, the EU has established a well-established regulatory framework on gender equality, including binding directives, which apply widely across the labour market including the research sector.</p>","PeriodicalId":9645,"journal":{"name":"Casopis lekaru ceskych","volume":"161 3-4","pages":"163-166"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33465552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Casopis lekaru ceskych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1